HomeCompareLEDOX vs JNJ

LEDOX vs JNJ: Dividend Comparison 2026

LEDOX yields 16.91% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LEDOX wins by $40.3K in total portfolio value
10 years
LEDOX
LEDOX
● Live price
16.91%
Share price
$11.83
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$60.3K
Annual income
$4,771.15
Full LEDOX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — LEDOX vs JNJ

📍 LEDOX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLEDOXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LEDOX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LEDOX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LEDOX
Annual income on $10K today (after 15% tax)
$1,437.02/yr
After 10yr DRIP, annual income (after tax)
$4,055.48/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, LEDOX beats the other by $3,351.86/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LEDOX + JNJ for your $10,000?

LEDOX: 50%JNJ: 50%
100% JNJ50/50100% LEDOX
Portfolio after 10yr
$40.2K
Annual income
$2,799.47/yr
Blended yield
6.97%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

LEDOX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LEDOX buys
0
JNJ buys
0
No recent congressional trades found for LEDOX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLEDOXJNJ
Forward yield16.91%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$60.3K$20.0K
Annual income after 10y$4,771.15$827.78
Total dividends collected$31.3K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: LEDOX vs JNJ ($10,000, DRIP)

YearLEDOX PortfolioLEDOX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,391$1,690.62$10,676$355.77+$1.7KLEDOX
2$15,216$1,957.74$11,407$389.39+$3.8KLEDOX
3$18,528$2,246.83$12,198$426.53+$6.3KLEDOX
4$22,381$2,556.90$13,056$467.62+$9.3KLEDOX
5$26,835$2,886.68$13,987$513.12+$12.8KLEDOX
6$31,948$3,234.64$14,998$563.56+$16.9KLEDOX
7$37,783$3,599.03$16,098$619.52+$21.7KLEDOX
8$44,406$3,977.94$17,295$681.69+$27.1KLEDOX
9$51,884$4,369.35$18,599$750.82+$33.3KLEDOX
10$60,287$4,771.15$20,022$827.78+$40.3KLEDOX

LEDOX vs JNJ: Complete Analysis 2026

LEDOXStock

The fund invests primarily in debt securities issued or guaranteed by governments, government agencies or supranational bodies or companies or other private-sector entities. It invests at least 80% of its assets in debt securities that are economically tied to emerging market countries. Emerging market countries include all countries not represented by the MSCI World Index. The fund is non-diversified.

Full LEDOX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this LEDOX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LEDOX vs SCHDLEDOX vs JEPILEDOX vs OLEDOX vs KOLEDOX vs MAINLEDOX vs ABBVLEDOX vs MRKLEDOX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.